![Thorsten P. Degenhardt](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Thorsten P. Degenhardt
Geschäftsführer bei Mycovia Pharmaceuticals, Inc.
Profil
Thorsten P.
Degenhardt is currently the Chief Operating Officer at Mycovia Pharmaceuticals, Inc. He previously worked as a Project Director at BioStratum, Inc. and as a Vice President-Drug Development at Cempra Pharmaceuticals, Inc. Prior to his industry experience, he was an Assistant Professor at the University of South Carolina.
Degenhardt holds a graduate degree from Technische Universität Darmstadt and a doctorate from Ruprecht-Karls-Universität Heidelberg.
Aktive Positionen von Thorsten P. Degenhardt
Unternehmen | Position | Beginn |
---|---|---|
Mycovia Pharmaceuticals, Inc.
![]() Mycovia Pharmaceuticals, Inc. BiotechnologyHealth Technology Mycovia Pharmaceuticals, Inc. develops novel drugs in areas of unmet medical need, with an initial focus in women?s health. Its product candidate, VT-1161, engages in developed as a treatment for recurrent vulvovaginal candidiasis. The company was founded in 2018 and is headquartered in Durham, NC. | Geschäftsführer | - |
Ehemalige bekannte Positionen von Thorsten P. Degenhardt
Unternehmen | Position | Ende |
---|---|---|
BioStratum, Inc.
![]() BioStratum, Inc. Pharmaceuticals: MajorHealth Technology BioStratum, Inc. develops and distributes pharmaceutical products. Its products are used for treatment of diabetes and diabetic complications. The firm also develops anti-tumor, cancer, diabetic kidney disease and diabetic eye disease drugs. The company was founded by Karl Tryggvason and J. Wesley Fox in 1994 and is headquartered in Durham, NC. | Corporate Officer/Principal | - |
University of South Carolina | Corporate Officer/Principal | - |
Cempra Pharmaceuticals, Inc.
![]() Cempra Pharmaceuticals, Inc. BiotechnologyHealth Technology Cempra Pharmaceuticals, Inc. develops medicines for treating drug-resistant bacterial infections. The firm's antibacterial products, both in clinical trials, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community. The company was founded by Prabhavathi B. Fernandes IN 2006 and is headquartered in Chapel Hill, NC. | Corporate Officer/Principal | - |
Ausbildung von Thorsten P. Degenhardt
Technische Universität Darmstadt | Graduate Degree |
Ruprecht-Karls-Universität Heidelberg | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Cempra Pharmaceuticals, Inc.
![]() Cempra Pharmaceuticals, Inc. BiotechnologyHealth Technology Cempra Pharmaceuticals, Inc. develops medicines for treating drug-resistant bacterial infections. The firm's antibacterial products, both in clinical trials, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community. The company was founded by Prabhavathi B. Fernandes IN 2006 and is headquartered in Chapel Hill, NC. | Health Technology |
BioStratum, Inc.
![]() BioStratum, Inc. Pharmaceuticals: MajorHealth Technology BioStratum, Inc. develops and distributes pharmaceutical products. Its products are used for treatment of diabetes and diabetic complications. The firm also develops anti-tumor, cancer, diabetic kidney disease and diabetic eye disease drugs. The company was founded by Karl Tryggvason and J. Wesley Fox in 1994 and is headquartered in Durham, NC. | Health Technology |
Mycovia Pharmaceuticals, Inc.
![]() Mycovia Pharmaceuticals, Inc. BiotechnologyHealth Technology Mycovia Pharmaceuticals, Inc. develops novel drugs in areas of unmet medical need, with an initial focus in women?s health. Its product candidate, VT-1161, engages in developed as a treatment for recurrent vulvovaginal candidiasis. The company was founded in 2018 and is headquartered in Durham, NC. | Health Technology |